Serge Saxonov - Nov 22, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Nov 22, 2021
Transactions value $
-$114,550
Form type
4
Date filed
11/24/2021, 08:08 PM
Previous filing
Nov 4, 2021
Next filing
Dec 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$115K -772 -0.09% $148.38 885K Nov 22, 2021 Direct F1
holding TXG Class A Common Stock 4.5K Nov 22, 2021 See footnote F2
holding TXG Class A Common Stock 90K Nov 22, 2021 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.